Redeye provides an initial comment on the Q2 2025 report from Serstech. Sales came in weaker than our estimates, with items further down the income statement following suit. We are somewhat surprised by the mentions of intensifying price pressure and general market weakness, which are expected to trigger downward revisions of our estimates. However, the company has now doubled its sales force, and, coupled with a pipeline described as strong, this should set the company up for a solid 2026.
LÄS MER
